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Dietary carbohydrate fibers are known to prevent immunological diseases common 
in Western countries such as allergy and asthma but the underlying mechanisms are 
largely unknown. Until now beneficial effects of dietary fibers are mainly attributed to 
fermentation products of the fibers such as anti-inflammatory short-chain fatty acids 
(SCFAs). Here, we found and present a new mechanism by which dietary fibers can be 
anti-inflammatory: a commonly consumed fiber, pectin, blocks innate immune receptors. 
We show that pectin binds and inhibits, toll-like receptor 2 (TLR2) and specifically inhibits 
the proinflammatory TLR2–TLR1 pathway while the tolerogenic TLR2–TLR6 pathway 
remains unaltered. This effect is most pronounced with pectins having a low degree 
of methyl esterification (DM). Low-DM pectin interacts with TLR2 through electrostatic 
forces between non-esterified galacturonic acids on the pectin and positive charges on 
the TLR2 ectodomain, as confirmed by testing pectin binding on mutated TLR2. The 
anti-inflammatory effect of low-DM pectins was first studied in human dendritic cells and 
mouse macrophages in vitro and was subsequently tested in vivo in TLR2-dependent 
ileitis in a mouse model. In these mice, ileitis was prevented by pectin administration. 
Protective effects were shown to be TLR2–TLR1 dependent and independent of the 
SCFAs produced by the gut microbiota. These data suggest that low-DM pectins as a 
source of dietary fiber can reduce inflammation through direct interaction with TLR2–
TLR1 receptors.
Keywords: dietary fiber, toll-like receptor 2, pectin, ileitis, degree of methyl esterification
inTrODUcTiOn
Lower intake of dietary fiber by Westerners (1) coincides with a higher prevalence of certain diseases, 
such as diabetes (2), obesity (3), asthma (4), allergies (5), inflammatory bowel disease (6), and colo-
rectal cancer (7). A number of these typical Western diseases, including asthma, allergies, and inflam-
matory bowel diseases have an immunological basis (8). Lower consumption of dietary fibers has 
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been proposed as the leading cause for the rise in immunological 
disorders in western societies (8–10). However, the underlying 
mechanisms that link dietary fiber consumption and immunity 
are largely unknown. Short-chain fatty acids (SCFAs) are one 
of the mediators (11). Dietary fibers may serve as fermentation 
substrate for gut microbiota, which generate SCFAs that in turn 
attenuate inflammation by enhancing numbers of immune regu-
latory Treg cells in the intestine (12). However, beneficial effects 
of dietary fibers independent of SCFAs have also been reported 
(13, 14), wherein direct immunomodulatory effects of dietary 
fibers on immune cells were proposed (15). More knowledge on 
mechanisms of beneficial effects of dietary fibers is required for a 
better insight in their potential application for health promoting 
effects.
Apart from a need for mechanistic insight, there is also a 
scientific and societal need to determine which dietary fibers 
are beneficial for immunity (16). Studies on the relation between 
dietary fiber intake and Western diseases make no distinction in 
types of fibers (4, 5), while it has been shown in vitro that only 
specific fibers contribute to immunity (15, 17). Also, health 
advisory groups only recommend on quantitative intake and not 
on consumption of specific types of fibers (16). Previous studies 
from us and others have shown that immunomodulation capaci-
ties of dietary fibers can differ even within one type of fiber. It 
was demonstrated that chemical differences such as variations 
in side chains and in chain length determine immune effects 
(15, 17). Knowledge on the role of chemical structure on immu-
nity such as effect of branching, and chain length of dietary 
fibers are therefore essential to understand and predict efficacy 
of dietary fibers.
Pectin is one such widely consumed dietary fiber having 
immunomodulatory effects. Pectin is the structural component 
of plant cell walls and is abundantly present in fruits. Pectins have 
α(1-4)-linked galacturonic acid backbone and can differ in degree 
of methyl esterification (DM). Dietary effects of pectin have been 
shown to be effective against endotoxin-induced inflammations 
(18–21) allergic airway inflammations (22), colitis (23), pancrea-
titis (24), and in supporting colonic anastomosis healing (25) in 
various animal models. Although anti-inflammatory effects of 
pectin are recognized, only a few studies have addressed mecha-
nistic differences of pectins with different DM values (18, 24, 25) 
and none of the studies addressed true binding or identification of 
specific immune receptor responsible for the anti-inflammatory 
effects.
We hypothesized that the chemistry dependent effects of pec-
tins may be caused by different binding capacities to interact with 
the so-called pattern recognition receptors (PRRs), as it has been 
demonstrated that some dietary fibers can have direct effects on 
immune cells by directly stimulating these innate immune sensors 
(15, 17, 26). Toll-like receptors (TLRs) are the best characterized 
PRRs expressed in the intestine (27–29) and have been shown to 
be involved in recognition of dietary fibers (17). Here, we studied 
the relation between DM value of pectins and the capacity to acti-
vate or inhibit TLRs as a possible mechanism by which pectins 
may have versatile immunomodulatory properties. To determine 
potential structure–function relationships we compared different 
citrus pectins having a range of DM levels. These pectins, except 
for a DM variation, have a relatively similar chemical structure 
allowing sound comparison of DM effects on TLR activation 
or inhibition. We investigated the effect on extracellular TLRs; 
TLR2, TLR4, and TLR5. The effects on TLR2 were also studied for 
the combined effects with the two heterodimers TLR2 forms with 
TLR1 and TLR6. This was done because TLR2 is unique in its 
ability to form heterodimers with other membrane receptors such 
as TLR1 or TLR6 to stimulate different activation pathways (30).
Here, we show that pectin with a low DM has predominantly 
TLR2 inhibiting effects similar to that of TLR2 antibodies while 
higher DM pectins are ineffective. Low-DM pectins interact with 
the TLR2–TLR1 heterodimer, which was confirmed by using an 
approach of ELISA containing tagged TLR2 and application of 
mutants of TLR2 in which potential binding sites were modified. 
To demonstrate principle applicability of the acquired structural 
insights, we tested the pectin efficacy in preventing TLR2-
dependent ileitis in a mice model. Our work provides to our opin-
ion novel insights in structure–function effector relationships of 
dietary fibers and enables us to rationalize contradictory findings 
on immune efficacy of dietary fibers. Also, our work provides 
novel insight in mechanisms of action of dietary fibers and can 
assist in generating more effective functional food formulations 
for promoting immune health and eventually contribute to a 
strategy for prevention of Western diseases.
MaTerials anD MeThODs
Pectin samples
Commercially extracted lemon pectins with different degree of 
methyl esterification (DM) (DM7, DM22, DM45, DM60, and 
DM75) were obtained from CP Kelco (Lille Skensved, Denmark). 
Endotoxin levels in pectin samples were confirmed with endo-
toxin detection kit (Thermo Scientific, Sunnyvale, CA, USA), and 
endotoxin levels were below detection level of 0.1 ng/ml.
characterization of Pectins
High performance size exclusion liquid chromatography was 
 performed on an Ultimate 3000 HPLC system (Thermo Scientific, 
Sunnyvale, CA, USA). A Super AW-L guard column (4.6  mm 
i.d. × 35 mm, Tosoh Bioscience, Tokyo, Japan) and three TSK-gel 
columns (6 mm i.d. × 150 mm) connected in series (4000, 3000, 
and 2500 SuperAW Tosoh Bioscience, Tokyo, Japan) were used 
for analysis. A sample of 20  µl (2.5  mg/ml in 10  mM sodium 
acetate buffer, pH 5.0) was injected and eluted with 0.2 M sodium 
nitrate at a flow rate of 0.6 ml/min at 55°C. The HPLC system 
was controlled by Chromeleon version 7. Detection was achieved 
with a refractive index detector Shodex R101 (Showa Denko, 
Japan). The molecular mass of polysaccharides was calculated 
using a calibration curve using pullulan standards (Sigma, St. 
Louis, MO, USA).
The DM of polysaccharides were determined by adding 0.8 mL 
of 0.4 N sodium hydroxide in 2-propanol/water (50/50 v/v) to 
10 mg pectin for 4 h and analyzing the acetic acid and methanol 
released by HPLC (31). The DM was calculated as moles of acetic 
acid or methanol per 100 mol of UA.
The constituent monosaccharide content and composition was 
determined by gas–liquid chromatography (32). Samples were 
TaBle 1 | The toll-like receptors (TLR) reporter cell lines, their agonists, and 
selection antibiotics.






HEK-Blue™ hTLR4 10 ng/ml LPS HEK-Blue™ Selection (1X)
HEK-Blue™ hTLR5 10 ng/ml Flagellin Blasticidin (30 µg/ml)
Zeocin (100 µg/ml)
HEK-Blue™ Null1 TLR2 100 ng/ml Pam3CSK4 Zeocin (100 µg/ml)
Hygromycin B (150 µg/ml)
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pre-hydrolyzed with 72% (w/w) H2SO4 for 1 h at 30°C followed 
by hydrolysis with 1 M H2SO4 for 3 h at 100°C. The monosac-
charides released were derivatized into their alditol acetates 
and determined by gas chromatography (Focus-GC, Thermo 
Scientific, MA, USA) using inositol as an internal standard. 
Uronic acid content was determined as anhydro-uronic acid 
content using an automated colorimetric m-hydroxydiphenyl 
assay (33) including 0.3% (w/w) tetraborate in the sulfuric acid.
cell lines
To study the interaction of pectin with TLRs, we used the 
HEK-Blue™ TLR cell based assays from InvivoGen, Toulouse, 
France. These HEK-Blue™ cells express the soluble embryonic 
alkaline phosphatase (SEAP) gene, which can be quantified using 
Quanti-Blue (InvivoGen, Toulouse, France). The SEAP gene is 
under the control of the NF-κB/AP-1 responsive promoter. 
These HEK-Blue™ cells also co-express single TLR genes. Upon 
activation with TLR specific agonists, NF-κB is activated leading 
to SEAP expression. We used HEK-Blue™ hTLR4, hTLR5 cells 
(InvivoGen, Toulouse, France), and HEK-Blue™ Null1 TLR2 
(developed by us) for studying the interaction of TLRs and pectins. 
HEK-Blue™ Null1 (InvivoGen, Toulouse, France) is the parental 
cell line for HEK-Blue™ TLR cells, expressing the SEAP gene, 
but not any TLR expression construct (34). Cell lines, antibiotics, 
and concentration of agonists used to activate TLR signaling are 
shown in Table 1. Mouse macrophage cells RAW264.7 (ATCC, 
VA, USA) were used to determine TLR2 inhibition using pectin.
HEK cells were cultured in DMEM culture media (Lonza, 
Basel, Switzerland), and RAW264.7 were cultured in RPMI culture 
media (Lonza, Basel, Switzerland) with 10% de-complemented 
fetal calf serum, 50  U/ml penicillin (Sigma, St. Louis, MO, 
USA), 50 µg/ml streptomycin (Sigma, St. Louis, MO, USA), and 
100 µg/ml normocin (InvivoGen, Toulouse, France).
Tlr2 ectodomain expression
RNA was extracted from HEK-Blue™ hTLR2 (InvivoGen, 
Toulouse, France) cells using RNeasy® Plus Mini kit (Qiagen, 
Venlo, The Netherlands). cDNA was synthesized using OligodT 
primers (Life Technologies, Carlsbad, CA, USA), dNTP mix 
(Life Technologies, Carlsbad, CA, USA), and Superscript™III 
Reverse Transcriptase (Life Technologies, Carlsbad, CA, USA). 
The first 586 codons of TLR2 were amplified from HEK-Blue™  
hTLR2 cDNA using forward primer 5′ GCGCACCGGTATGC 
CACATACTTTGTGGATGG 3′ and reverse primer 5′ GCGC 
GGATCCGTGACATTCCGACACCGAGAG 3′ with Pfu DNA 
polymerase (Thermo Scientific, Waltham, MA, USA). Primers 
were flanked by a 5′ GC doublet for improved restriction enzyme 
digestion. Underlined letters represent AgeI and BamHI restric-
tion sites for forward and reverse primers, respectively. Fast digest 
restriction enzymes (Thermo Scientific, Waltham, MA, USA) 
were used to digest the PCR product and pSELECT-CHA-blasti 
(InvivoGen, Toulouse, France) to create sticky ends. After ligation 
using T4 DNA Ligase (Thermo Scientific, Waltham, MA, USA), 
the mixture was used to transform One Shot TOP10 Chemically 
Competent E. coli (Life Technologies, Carlsbad, CA, USA). 
Transformed E. coli were selected on Blasticidin agar media 
(InvivoGen, Toulouse, France), and colonies were screened for 
correct orientation of the gene. Selected colonies were grown 
in Blasticidin liquid media (InvivoGen, Toulouse, France) after 
which the isolated plasmid (Midi prep kit, Qiagen, Venlo, The 
Netherlands) was sequenced (Baseclear, Leiden, The Netherlands) 
to confirm non-mutated clones.
selection of amino acids on Tlr2 for 
Mutant Development
As negatively charged pectin (DM7) could inhibit TLR2, we ana-
lyzed amino acids lying close to the ligand binding site on TLR2. 
We chose R315, R316, R321, and K347 amino acids (R-arginine 
and K-lysine) as putative pectin binding site on TLR2. R321 and 
R347 were selected as these positively charged amino acids were 
involved in binding between TLR2 and TLR1 interfaces (35). 
R315 and R316 were selected as these amino acids were struc-
turally close to the ligand binding site of TLR2. The structural 
proximity of these amino acids on TLR2 structure was confirmed 
using PyMOL program (Schrödinger, New York, NY, USA).
Development of Tlr2 Mutant cell lines
The TLR2 gene sequence was changed at amino acid locations 
R315, R316, R321, and K347. The positively charged amino acids 
arginine (R) and lysine (K) were mutated at above locations to 
express uncharged amino acid glutamine (Q). The mutants were 
designed to have R315, R316, Q321, Q347 (TLR2-RRQQ) and 
Q315, Q316, Q321, and Q347 (TLR2-QQQQ). The TLR2-RRQQ 
and TLR2-QQQQ were synthesized by GeneArt AG service 
(Regensburg, Germany) with the hemagglutinin (HA) tag gene 
on the C-terminal and cloned in pcDNA™ 3.1 (+) Hygro plas-
mid (Life Technologies, Carlsbad, CA, USA). The plasmid was 
expanded in One Shot TOP10 Chemically Competent E. coli (Life 
Technologies, Carlsbad, CA, USA) and purified using Midi prep 
kit (Qiagen, Venlo, Netherlands). The plasmid was then linearized 
with Mfe I fast digest enzyme (Thermo Scientific, Waltham, MA, 
USA). The linearized plasmid was then transfected in HEK-
Blue™ Null1 (InvivoGen, Toulouse, France) using Lipofectamine 
LTX® (Life Technologies, Carlsbad, CA, USA).
Plasmid Transfection for stable cell line 
Development
HEK-Blue™ Null1 TLR2, HEK293T TLR2ectodomain-HA, 
HEK-Blue™ Null1 TLR2-RRQQ, and HEK-Blue™ Null1 TLR2-
QQQQ cell lines were obtained by transfecting cells with NotI 
(Thermo Scientific, Waltham, MA, USA) linearized plasmids. 
TaBle 2 | Parental cell lines, expression plasmids and selection antibiotics used to develop toll-like receptor 2 (TLR2) expression cell lines.
name of the cell line Parental cell line Plasmid for transfection selection antibiotics (invivogen)
HEK293T TLR2ectodomain-HA HEK293T TLR2ectodomain in pSELECT-CHA blasti Blasticidin (50 µg/ml)
HEK-Blue™ Null1 TLR2 HEK-Blue™ Null1 pUNO3-hTLR2 (InvivoGen) Zeocin (100 µg/ml) and hygromycin B (150 µg/ml)
HEK-Blue™ Null1 TLR2-RRQQ HEK-Blue™ Null1 pcDNA™3.1 (+) Hygro plasmid-TLR2 RRQQ Hygromycin B (200 µg/ml) and Zeocin (100 µg/ml)
HEK-Blue™ Null1 TLR2-QQQQ HEK-Blue™ Null1 pcDNA™3.1 (+) Hygro plasmid-TLR2 QQQQ Hygromycin B (200 µg/ml) and Zeocin (100 µg/ml)
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Plasmids, antibiotics, and parental cell lines are listed in Table 2. 
The parental cell line was seeded at 500,000 cells/ml in 12-well 
culture plates and incubated overnight. The following day, 
transfection was performed using Lipofectamine LTX® (Life 
Technologies, Carlsbad, CA, USA). Purified, 1 µg linear plasmid 
was diluted in low serum media Opti-MEM® (Life Technologies, 
Carlsbad, CA, USA) and mixed with 3.5  µl of Lipofectamine 
LTX® (Life Technologies, Carlsbad, CA, USA). This transfection 
mix was incubated for 30  min at room temperature and then 
added to the previously seeded cells in the culture media. Cells 
were incubated with transfection medium mix for 24  h, and 
transfected cells were selected using antibiotics. Single cell clones 
were selected for each newly developed cell line.
Tlr activation and inhibition assay
HEK-Blue™ cell lines were seeded at 500,000 cells/ml in 96-well 
plates at 100  μl/well. Cells were allowed to grow overnight. 
The following day, to study whether pectins can activate TLRs, 
cells were treated with different pectins at 2  mg/ml or TLR 
agonists as control (Table 1). Inhibition of TLR was studied by 
pretreating HEK-Blue™ cells with pectin (0.5, 1, or 2  mg/ml) 
for 1  h, followed by treatment with TLR agonists (Table  1). 
Activity of SEAP converts the pink QUANTI-Blue substrate to 
blue. Media supernatant was mixed with QUANTI-Blue in a ratio 
of 1:10 and NF-κB activation was quantified at 650 nm using a 
Versa Max ELISA plate reader (Molecular Devices, Sunnyvale, 
CA, USA). The assay was performed with five technical repeats. 
Each experiment was at least repeated three times.
Dialysis Binding assay of Pectin  
with Tlr agonist
Pectin was dissolved in 1 mM CaCl2 and 150 mM NaCl in 0.05 M 
Tris buffer pH 8.2 at 0.5, 1, and 2 mg/ml. Rhodamine-labeled 
Pam3CSK4 (InvivoGen, Toulouse, France) was added at 10 µg/ml 
and incubated overnight at 37°C. After incubation, 100  µl of 
this solution was applied to a 10  kDa molecular weight cut 
off microdialysis chamber (Thermo Scientific, Waltham, MA, 
USA). As pectin is larger than 10  kDa, it does not diffuse 
out of the microdialysis chamber, while the smaller 2.15 kDa 
Pam3CSK4 will diffuse out. In the case of an interaction between 
the TLR2 ligand Pam3CSK4 and pectin, the complex will stay 
inside the dialysis chamber and fluorescence will increase. 
The microdialysis chamber was washed with 1  mM CaCl2 
and 150 mM NaCl in 0.05 M Tris buffer pH 8.2. Samples were 
dialyzed for 4 h, with buffer change every hour. After dialysis, 
samples were recovered from the chamber and fluorescence 
intensity was measured at 566 nm (excitation at 549 nm) using 
a Varioskan reader (Thermo Scientific, Waltham, MA, USA). 
Non-dialyzed and dialyzed Pam3CSK4 rhodamine in buffer 
was used as controls. Dialysis was performed three times for 
each test sample.
immunofluorescence
Human monocytic THP-1 cells (American Type Culture Collec-
tion) were cultured in RPMI 1640 medium (Lonza, Belgium) 
with 10% fetal bovine serum (Sigma-Aldrich, MO, USA), 2 mM 
l-glutamine (Lonza, Belgium), 1 mM sodium pyruvate (Lonza, 
Belgium), 0.05 mM 2-mercaptoethanol (Scharlau, Spain), 60 µg/ml 
gentamicin sulfate (Lonza, Belgium), and 2.2 µg/ml amphotericin 
B solubilized (Sigma-Aldrich, MO, USA). THP-1 cell differentia-
tion was induced by stimulation of THP-1 cells (1 × 106 cells/ml) 
with 100 ng/ml Phorbol 12-myristate 13-acetate (PMA, Sigma-
Aldrich) in an 8-wells chambered coverglass (Thermo Scientific, 
Nunc Lab-Tek, USA) for 48 h at 37°C and 5% CO2. The adherent 
cells were washed with PBS (Westburg, Netherlands) to remove 
PMA and they were then fixed for 15 min. with 4% paraform-
aldehyde (Merck, Germany). Subsequently, the cells were blocked 
with 10% goat serum (Sigma-Aldrich, MO, USA) for 1  h. The 
cells were incubated with the TLR2.1 FITC-conjugated antibody 
(1:200; ab13553, Abcam) for 1  h. Next, the cell was treated 
for 24  h with PBS, DM7 pectin, or DM75 pectin (1  mg/ml). 
After pectin treatment, the cells were incubated for 1  h with a 
rat anti-pectin primary antibody, specific for DM7 pectin (1:200; 
LM19, PlantProbes, University of Leeds, UK) or DM75 pectin 
(1:200; LM20, PlantProbes, University of Leeds, UK). Next, the 
cells were incubated for 30  min. with the secondary antibody 
for pectin goat-anti-rat Alexa Fluor 594-conjugated (1:500; Life 
Technologies, USA). DAPI (1.0 ug/ml; Roche, Switzerland) was 
incubated for 1  min on the cells and used as counterstain. In 
the end, the cells were covered with 250 µl PBS. The cells were 
washed thrice with 1× PBS between each incubation step, and all 
 incubation steps were performed at 37°C and 5% CO2. Fluorescent 
confocal microscopy was measured using a Leica TCS SP8 AOBS 
confocal microscope (Leica Microsystem, Germany) equipped 
with an objective HC PL APO CS2 40×/0.30, immersion oil. All 
pictures were zoomed 6.00×. Data were processed and merged 
using ImageJ 1.47 Software (NIH, USA).
Protein immunoprecipitation
HEK293T TLR2ectodomain-HA, HEK-Blue™ Null1 TLR2-
RRQQ, and HEK-Blue™ Null1 TLR2-QQQQ cells were lysed 
using RIPA lysis buffer (Merck Millipore, Billerica, MA, USA) 
with a protease inhibitor cocktail (Sigma, St. Louis, MO, USA) 
at 4°C for 10 min followed by two times sonication (Bandelin, 
Berlin, Germany) for 5 s at 50% power. Supernatant was collected 
after centrifugation at 14,000 g for 10 min. HA tagged proteins 
were immunoprecipitated using Pierce® Anti-HA Agarose in 
a microcentrifuge tube. Protein was eluted using HA peptide 
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(Thermo Scientific, Waltham, MA, USA) by incubating two times 
for 15 min with single bed volume of HA peptide at 30°C. Isolated 
protein was desalted and HA peptide was removed using Zeba 
Spin Desalting Columns and Devices, 40  K MWCO (Thermo 
Scientific, Waltham, MA, USA). Isolated desalted protein was 
quantified using the Thermo Scientific BCA protein assay kit 
(Thermo Scientific, Waltham, MA, USA).
elisa for Binding of Tlr2 and Pectin
ELISA buffer consisted of 1  mM CaCl2 and 150  mM NaCl in 
0.05 M Tris buffer at pH 8.2. The buffer was used for washing 
as well as diluent for antibodies and pectin. Blocking buffer 
was made by adding 3% milk powder (FrieslandCampina, 
Amersfoort, The Netherlands) to the ELISA buffer. For antibody 
solutions, 1:2 dilution of blocking buffer with ELISA buffer was 
used. ELISA plates (Corning, Tewksbury, MA, USA) were treated 
with 50 µl of 50 µg/ml of poly-l-lysine for 1 h at 37°C. Wells were 
washed once with 400 µl ELISA buffer. Pectins were dissolved in 
ELISA buffer at 1 mg/ml and 50 µl was applied to each well. The 
plates were incubated for 4 h at 37°C. Each well was then washed 
with 400 µl buffer and blocked overnight with 100 µl blocking 
buffer at 4°C. After blocking, the plate was washed once with 
ELISA buffer. Isolated TLR2 protein and HA peptide (Thermo 
Scientific, Waltham, MA, USA) were applied to pectin-coated 
wells at 0.33, 1, 3, and 9 µg/well; and incubated at 37°C for 3 h. HA 
peptide was used as a negative control. Pectin binding antibod-
ies LM19 (DM7) and LM20 (DM22, DM45, DM60, and DM75) 
(Plantprobes, Leeds, UK) were used as positive control for pectin 
binding at 1:100 dilutions, to confirm even pectin immobilization. 
Afterward, wells were washed with 400 µl of ELISA buffer for five 
times and incubated with 50 µl primary HA tag antibody (Cell 
Signaling, Danvers, MA, USA) at 1:200 dilutions. Primary anti-
body was incubated for 2 h at 37°C. Afterward, plates were washed 
five times with ELISA buffer and subsequently, 50  µl of biotin 
tagged secondary antibody (Southern Biotech, Birmingham, AL, 
USA) was applied to each well at 1:500 dilutions. Biotin tagged 
antibody was incubated for 1 h at 37°C followed by five wash-
ings with 400 µl of ELISA buffer. Streptavidin-HRP (100 µl) was 
applied to each well at 1:1,000 dilutions. Anti-rat HRP antibodies 
(Cell Signaling, MA, USA) (1:500 for 1 h at 37°C) were used to 
detect pectin binding antibodies in control wells. In the final step, 
100 µl TMB (Cell Signaling, MA, USA) was added as substrate for 
quantification and incubated at 37°C for 30 min. The reaction was 
stopped by addition of 100 µl of stop solution (Cell Signaling, MA, 
USA). Read out was done in a Versa Max plate reader (Molecular 
Devices, Sunnyvale, CA, USA) at 420  nm. The pectin loading 
control was confirmed to be at similar levels for all the pectin.
Doxorubicin-induced ileitis in Mice
C57BL/6 female mice (7–10 weeks) were obtained from Janvier 
Laboratories, France. The experimental use of animals was 
approved by the Animal Ethical Committee of the University of 
Groningen. All the mice were acclimatized for 2.5 weeks before 
start of the experiment. Mice were fed ad libitum with RMH-B 
(AB Diets, Woerden, The Netherlands). The ingredients of the 
diet specified by supplier were as follows: wheat, meat meal (80% 
sterilized), yellow dent corn, whole oats, wheat middlings, alfalfa, 
soya oil, dried yeast, dicalcium phosphate, calcium carbonate, 
NaCl, dl-methionine, vitamins, and trace elements. As pectin is 
present mainly in fruits and vegetables, the basal of level of pectin 
in diet was minimal. Mice were supplied with drinking water 
from the tap and the water bottles were changed once a week.
Ileitis was induced by administration of doxorubicin (Sigma, 
St. Louis, MO, USA). Doxorubicin was dissolved in sterile 0.9% 
sodium chloride and stored in aliquots at 4°C. Pectin was dis-
solved in sterile water and administered by gavage to mice for 
10 days, twice a day at a dose of 1.5 mg per gavage. On day 8, 
doxorubicin was injected intraperitoneally (IP) at 10  mg/kg. 
Mice were sacrificed on day 10 (48 h after doxorubicin). Animals 
receiving water by gavage served as controls. After the collection 
of tissue samples, mice were sacrificed by cervical dislocation.
Toll-like receptor 2 blocking antibody, clone T2.5 (InvivoGen, 
Toulouse, France) was administered IP at 10  mg/kg 1  h before 
doxorubicin treatment. The dose and concentration of TLR2 block-
ing antibody were used in accordance with Tye et al. (36). TLR2 
blocking antibody was also administered in additional controls to 
study possible immune effects of TLR2 blocking antibodies in mice.
neutrophil counts in Peritoneal lavage
Peritoneal lavage was collected by injection and aspiration of 2 ml 
PBS. The total number of living cells in the peritoneal lavage, 
lysed with lyserglobin, was counted using a Z™ Series coulter 
counter® (Beckman Coulter, Brea, CA, USA). The lavage was 
diluted to 500,000 cells/ml, and 100 µl of cell solution was applied 
for cytospin preparation. The cytospin slides were stained with 
Giemsa (Merck Millipore, Billerica, MA, USA) for 1 h at room 
temperature. The stained slides were scanned using a Hamamatsu 
slide scanner (Hamamatsu Photonics, Hamamatsu, Japan), and 
neutrophils were counted using morphological features in 250 
cells (37). The total number of neutrophils was calculated using 
the total cell count of the peritoneum and the neutrophil counts 
from cytospin preparations.
histology
Ileal samples from mice were fixed in 10% formalin in PBS and 
embedded in paraffin. Paraffin blocks were cut in 4 µm sections. 
The tissue sections were analyzed for apoptosis in crypts using 
a TUNEL assay. The TUNEL assay was performed using the 
ApopTag® Peroxidase In  Situ Apoptosis Detection Kit (Merck 
Millipore, Billerica, MA, USA) according to the instructions of 
the manufacturer. Hematoxylin was used for counterstaining 
the slides. As peroxidase substrate, an incubation step of 15 min 
with 3-amino-9-ethylcarbazole (AEC) (5% AEC stock; 95% 
0.05 M acetate buffer pH 4.9; 0.1% of 30% v/v H2O2) (Merck 
Millipore, Billerica, MA, USA) was used. The stained slides 
were scanned with a Hamamatsu slide scanner (Hamamatsu 
Photonics, Hamamatsu City, Japan), and analysis was performed 
using NDP.view2 Software. TUNEL positive cells were measured 
in 10 sequential crypts in the ileum per mouse.
cytokine Measurement Using luminex 
assays and elisa
Peritoneal lavage from mouse was centrifuged to remove the 
immune cells and the supernatant was stored at −20°C. Blood 
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was collected from mice through heart puncture and stored on 
ice in EDTA coated tubes (Greiner Bio-One, Kremsmünster, 
Austria). The tubes were centrifuged at 1,350  g for 10  min to 
separate plasma from the blood and stored at −20°C. Peritoneal 
lavage and plasma samples were analyzed in a luminex assay. 
TNF-α, MCP-1, IL-6, IP-10, and GRO-α were analyzed in the 
luminex assay (Affymetrix, Santa Clara, CA, USA).
Human umbilical cord dendritic cells (MatTek, Ashland, MA, 
USA) were seeded in a 96-well culture plates at 100,000 cells/ml 
in 100 µl dendritic maintenance medium provided by the sup-
plier (MatTek, Ashland, MA, USA). After 24 h at 37°C, each well 
was treated with DM7 or DM75 pectin at 1, 10, and 100 µg/ml, 
dissolved in culture media. Similarly, TLR2 blocking antibody 
(InvivoGen, Toulouse, France) was applied as positive control at 
10 µg/ml. Non-treated dendritic cells were used as negative con-
trol. After 1 h of pretreatment, 10 ng/ml of Pam3CSK4 was added. 
Dendritic cells treated with Pam3CSK4 or pectin only were used 
as control. After 24  h incubation, media supernatant was used 
to quantify IL-6 and IL-10 using the luminex assay (Affymetrix, 
Santa Clara, CA, USA).
RAW264.7 cells were seeded in 24-well plates at 106 cells/
well in RPMI medium with 10% FCS at a total volume of 500 µl. 
After 24  h at 37°C, each well was treated with DM7 or DM75 
pectin at 1, 10, and 100 µg/ml dissolved in culture media. TLR2 
blocking antibody (InvivoGen, Toulouse, France) was applied as 
positive control at 10 µg/ml. Non-treated RAW264.7 were used as 
negative control. After 1 h of pretreatment with pectin or TLR2 
blocking antibody, 20 ng/ml of Pam3CSK4 was added. RAW264.7 
treated with Pam3CSK4 or pectin only were used as control. After 
24  h incubation, media supernatant was used to quantify IL-6 
and IL-10 using ELISA (R&D Systems, MN, USA). ELISA was 
performed according to instructions from manufacturer.
The luminex assay was performed according to instructions 
from manufacturer. The antigen standards provided with the 
luminex kit (Affymetrix, Santa Clara, CA, USA) were dissolved 
and diluted fourfold to have seven serially diluted standards. 
DC-MM (MatTek, MA, USA) culture media was used as blank. 
The magnetic beads were added to a clear base, black 96-well 
plate at 50 µl/well and washed with a hand-held magnetic plate 
holder with 150 µl of the wash buffer provided in kit. The plasma 
samples were diluted with universal assay buffer in 1:2 dilution. 
The standards and samples in duplicates were applied to the 
magnetic beads, mixed on a plate shaker and incubated overnight 
at 4°C on a stable flat surface. The following day, magnetic beads 
were washed three times as mentioned earlier and incubated 
with 25 µl/well of detection antibody mix for 30 min on a plate 
shaker at room temperature. The plate was washed three times 
and incubated with 50 µl/well streptavidin-PE for 30 min at room 
temperature on a plate shaker. In the last step, the 96-well plate 
was washed three times and beads were dispersed in 120 µl of 
reading buffer per well and read in a Luminex-100 instrument 
with StarStation software.
Organic acids and scFa Measurement
Wet digests from cecum (200 mg) and colon of mice was mixed 
with 1.5 ml of 0.3 mg/ml 2-ethylbutyric acid (internal standard) 
in 50 mM H2SO4. After centrifugation (10,000 g, 5 min, 20°C), 
the supernatant was transferred into a vial for injection using an 
HPLC method as described (38).
statistics
The results were analyzed using Graphpad Prism program (La 
Jolla, CA, USA). The parametric distribution of data was con-
firmed using Kolmogorov–Smirnov test. Values are expressed 
as mean  ±  SD except where nonparametric, in which case 
median ± range was used. Statistical comparisons were performed 
using two-way ANOVA for grouped analysis of parametrically 
distributed data. Where no parametric distribution could be 
demonstrated, we applied Mann–Whitney U-test or Kruskal–
Wallis test. p <  0.05 was considered as statistically significant 
(*p < 0.05, **p < 0.01, and ***p < 0.001).
resUlTs
Pectin inhibits Tlr2 signaling in a  
Degree of Methyl esterification and 
concentration-Dependent Manner
To study the effects of chemical composition of pectin on the 
immune properties, we chemically characterized citrus pectin 
with different degrees (percent) of methyl esterification (DM7, 
DM22, DM45, DM60, and DM75) and studied activation and 
inhibition of TLR signaling. The pectins had average molecular 
weights ranging from 50 to 300  kDa and were predominantly 
composed of d-galacturonic acid (Figure 1). To determine TLR 
activation by pectins, the pectins were incubated with HEK293 
NF-κB reporter cell lines expressing extracellular TLRs (TLR2, 
TLR4, and TLR5). TLR activation with specific ligands in reporter 
cell lines results in NF-κB activation, which can be quantified 
through expression of SEAP gene transcribed through an NF-κB 
controlled promoter. As shown in Figure 2A pectins were unable 
to activate TLRs. It was never more than 10% of the positive 
controls (Figure 2A).
Pectins had a pronounced inhibitory effect on specific TLR 
receptors (Figure 2B) Inhibitory effects of pectin were studied 
by adding a TLR agonist to TLR reporter cell lines pretreated 
with pectin. As shown in Figure 2B; Figure S2 in Supplementary 
Material, pectin strongly inhibited TLR2 activation and minimally 
inhibited TLR4 and TLR5. There was a clear DM-dependent 
effect, as inhibition of TLR2 by lower DM pectins was more 
pronounced than with pectins of higher DM. Pectin DM7 sup-
pressed TLR2 activation by 91.1 ± 0.8% (p < 0.001) at the lowest 
concentration tested (0.5  mg/ml) (Figure  2B). Increasing the 
concentration enhanced the efficacy of higher DM pectins to 
inhibit TLR2 (Figure 2B).
Pectin inhibits Tlr2–Tlr1 activation  
but not Tlr2–Tlr6
Toll-like receptor 2 is activated by forming heterodimers with 
either TLR1 or TLR6. TLR2 activation with either TLR1 or TLR6 
stimulates different pathways (30). As such, the TLR2 reporter 
cell line also expresses TLR1 and TLR6 (39). TLR2–TLR1 is 
specifically activated by a tri-acylated lipopeptide, P3CSK4 
agonist. As shown in Figure  2B, the TLR2–TLR1 dimer was 
FigUre 1 | High pressure size exclusion chromatography elution patterns of pectin with monosaccharide composition (mol%) and carbohydrate content (w/w%).
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inhibited by pectin in a DM- and concentration-dependent 
manner. The other heterodimer, TLR2–TLR6, is activated 
by diacylated lipopeptides, such as FSL-1 (40). To determine 
if pectin also inhibits TLR2–TLR6 activation, different DM 
pectins were evaluated with FSL-1 as an agonist. As shown in 
Figure  2C, pectin did not substantially inhibit TLR2–TLR6. 
Thus, pectin only inhibits TLR2–TLR1 but does not inhibit 
TLR2–TLR6 activation.
Pectin inhibits Tlr2 by Direct Binding to 
Tlr2 ectodomain by electrostatic 
interactions
We performed four experiments to confirm the interaction 
between TLR2 and pectin. In the first experiment, we excluded 
the possibility that TLR2 inhibition was due to binding of pectin 
to the ligand P3CSK4. In the second and third experiment, we 
studied direct binding between pectin and TLR2 by immuno-
fluorescence and ELISA. In the fourth, we identified the sites on 
TLR2 involved in binding to pectin by generating TLR2 mutants 
at predicted binding sites.
In the first experiment, pectin was co-incubated with fluo-
rescently labeled P3CSK4 and dialyzed using a 10 kDa selective 
dialysis membrane permissible to P3CSK4 but not to pectin. As 
shown in Figure 3A, pectin did not bind P3CSK4, as fluorescence 
decreased profoundly upon dialysis. Also, there was no difference 
between fluorescence levels of dialyzed P3CSK4 with and without 
pectin. Thus, pectin does not bind to the TLR2–TLR1 agonist 
P3CSK4.
To determine direct binding between pectin and TLR2, we first 
studied the combined presence of pectin and TLR2 on the cell 
membrane of TLR2-expressing THP-1 macrophages by immu-
nostaining. As shown in Figure 3B, we observed co-staining of 
TLR2 (green) and pectin (red). The differentiated THP-1 cells 
were treated with DM7 and DM75 pectin. We observed a bright 
staining of DM7 pectin on the cell surface as well as of TLR2. With 
DM75 pectin we found no staining on the cell surface illustrating 
its inability to bind to TLR2. To further confirm, we developed a 
specific ELISA assay to demonstrate binding of pectin to TLR2. 
To this end, we made cell lines expressing the TLR2 ectodomain 
consisting of the ligand binding site. It was C-terminally fused to 
an HA tag. The TLR2 ectodomain protein was extracted, purified 
and applied to a direct ELISA containing immobilized pectin 
(Figure S1 in Supplementary Material). As shown in Figure 3C, 
TLR2 binding to pectin was DM dependent, wherein lower DM 
pectins showed stronger binding to TLR2 while minimal bind-
ing was observed for high-DM75 pectin. Thus, we confirm that 
inhibition of TLR2 was by binding of pectin to TLR2 and that 
lower DM pectins can bind more readily to TLR2 than high-DM 
pectins.
To determine how and where low-DM pectins can bind 
to TLR2 we searched for potential binding sites on TLR2. As 
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low-DM pectins are hydrophilic and more negatively charged 
than higher DM pectins we hypothesized that the positively 
charged amino acids at positions R315, R316, R321, and K347 
surrounding the ligand binding site are responsible for interac-
tion with low-DM pectin (Figure 3D). To test this, we developed 
TLR2 mutants wherein we substituted amino acids R315, R316, 
R321, and K347 to the uncharged amino acid glutamine (Q). 
R321 and K347 have been shown to be involved in TLR2 and 
TLR1 interface binding (35). R315 and R361 were mutated as 
these positively charged amino acids lie structurally in prox-
imity of the ligand binding site of TLR2 (35). We developed 
two mutants wherein only R321 and K347 were changed to Q 
(RRQQ) or all the amino acids were changed to Q (QQQQ) to 
allow comparison of binding kinetics. As shown in Figure 3E, 
the DM7 pectin showed lower binding with TLR2-QQQQ 
than TLR2-RRQQ (p < 0.01). Whereas we did not observe any 
difference in binding of DM75 pectin with both of the TLR2 
mutants. This confirms that the pectin interacts with TLR2 
through electrostatic forces at the R315, R316, R321, and K347 
sites. The higher level of binding observed to the TLR2 mutants 
compared with the TLR2 ectodomain might be due to the use of 
full-length TLR2 constructs in TLR2 mutants than in the TLR2 
ectodomain.
Pectin inhibits Tlr2–Tlr1 in human 
Dendritic cells and in Mouse Macrophage 
cell line raW264.7
The effect of DM of pectin on TLR2–TLR1-dependent inhibition 
of immune responses was also studied in human dendritic cells 
and in the mouse macrophage cell line RAW264.7. Dendritic 
cells and RAW264.7 cells were stimulated with P3CSK4 in the 
presence of the TLR2 inhibiting pectin DM7 and a weak TLR2 
inhibiting pectin DM75. Production of the P3CSK4-dependent 
cytokines IL-6 (41) and IL-10 (42) were used to assess the effects. 
Concentration- and DM-dependent effects were observed for 
TLR2 inhibition by pectin (Figure 4). In dendritic cells, at high 
concentrations (100 µg/ml), both DM7 and DM75 pectin reduced 
IL-6 and IL-10 production. However, at lower concentrations (10 
and 1 µg/ml) only DM7 pectin reduced IL-6 and IL-10 production 
(p < 0.001). Remarkably, the inhibition potency of DM7 pectin 
was similar, if not identical, to that of a TLR2 blocking antibody 
(Figure 4A). In RAW264.7 cells, DM7 reduced P3CSK4 induced 
IL-6 production at 100  µg/ml, while DM75 was ineffective in 
reducing IL-6 production (Figure 4B). IL-10 production could 
not be induced in RAW264.7 cells using P3CSK4 (data not shown). 
Thus pectin DM7 can reduce P3CSK4 induced cytokine produc-
tion in both human dendritic cells and in mouse macrophages.
FigUre 2 | Continued
FigUre 2 | Pectin inhibits toll-like receptor 2 (TLR2)–TLR1, but not TLR2–TLR6, in a DM-dependent manner. (a) Toll-like receptor (TLR) activation represented as 
NF-κB activation of HEK-Blue™ TLR stimulated with pectin at 2 mg/ml concentration and with P3CSK4, LPS, and Flagellin as positive control for TLR2, TLR4, and 
TLR5 activation, respectively (n = 5). Data are presented as median ± range. The statistical differences between pectin samples were quantified using Kruskal–Wallis 
test. (B) TLR inhibition in HEK reporter cell lines for TLR2, TLR4, and TLR5, which were pretreated with pectin followed by activation by P3CSK4, LPS, and Flagellin, 
respectively (n = 5). (c) TLR2–TLR6 inhibition by pectin in HEK TLR2 reporter cells, which were pretreated with pectin and followed by stimulation with FSL-1 
(n = 5). Data are presented as the mean ± SD, and statistical significance was calculated using two-way ANOVA analysis (*p < 0.5, **p < 0.01, and ***p < 0.001).
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FigUre 3 | Continued
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FigUre 3 | Continued
FigUre 3 | Low-DM pectin inhibits toll-like receptor 2 (TLR2)–TLR1 by directly binding to the TLR2 ectodomain through electrostatic interactions (a) P3CSK4 
rhodamine interactions with pectin presented as fluorescence retention in the dialysis membrane compared with non-dialyzed samples (n = 3). (B) Immuno-
fluorescence co-staining of TLR2 (green) with DM7 or DM75 pectin (red). Sec. ab are the secondary antibody controls for TLR2, DM7, and DM75 antibodies (n = 3). 
(c) TLR2 ectodomain binding to pectins with various DM. Isolated hemagglutinin peptide was used as a negative control (n = 3). (D) TLR2 crystal structure with 
P3CSK4 and R315, R316, R321, and K347. (e) TLR2 mutants, TLR2-RRQQ and TLR2-QQQQ binding to DM7 and DM75 pectin (n = 3). Data are presented as  
the mean ± SD, and statistical significance was calculated using two-way ANOVA analysis (*p < 0.05 and ***p < 0.001).
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Pectin is Protective against  
Tlr2-Dependent ileitis in Mice
To confirm efficacy of TLR2 inhibition by low-DM pectin in vivo, 
DM7 pectin was tested for suppression of TLR2-dependent ileitis 
induced by doxorubicin in a mouse model. Doxorubicin induces 
massive cell death in intestinal crypts and immune cells (37), 
which leads to the release of damage-associated molecular pat-
tern molecules (DAMPs) that induce a strong TLR2-dependent 
inflammatory response which is subdued in TLR2 knockout 
mice compared with the wild-type mice (37). Pectin DM7 was 
administered for 1  week at 3  mg/day followed by doxorubicin 
treatment for 48  h. Pectin administration was continued until 
the animals were sacrificed. Initial symptoms of doxorubicin-
induced ileitis included neutrophil influx in the peritoneum (43) 
and cell death in crypts of the small intestine (37), as shown in 
doxorubicin-treated controls (Figures 5A,B). Neutrophil influx 
and cell death in the crypts were statistically significantly lower 
in mice with doxorubicin-induced ileitis treated with pectin 
DM7 (p < 0.01) (Figures 5A,B) than in mice treated with doxo-
rubicin only. Strong inhibitory effect of pectin DM7 on ileitis are 
illustrated by the reduction in neutrophil influx and cell death in 
the crypts that was similar to the reduction in mice treated with 
TLR2 blocking antibodies (p < 0.01) (Figures 5A,B).
Toll-like receptor 2–TLR1 activation has been reported to 
lead to proinflammatory responses (41, 44). The cytokine profile 
in  peritoneal fluid of mice demonstrates that pectin indeed 
specifically inhibited the TLR2–TLR1-induced proinflamma-
tory response. DM7 pectin treatment reduced production of the 
 proinflammatory cytokines TNF-α (p < 0.05), MCP-1 (p < 0.01), 
GRO-α (p < 0.05), and IL-6 (p < 0.01) (Figure 5C), with a similar 
efficacy to that of TLR2 blocking antibodies in doxorubicin-
treated mice. The immune regulatory cytokine IL-10 remained 
unchanged after pectin treatment in doxorubicin-treated mice 
(Figure  5C) suggesting that the regulatory pathway remained 
unaffected.
anti-inflammatory effects of Pectin  
are not through stimulated scFa 
Production
It might be suggested that attenuation of immune responses in 
mice may not be entirely caused by direct interaction with TLR2, 
but might be supported by anti-inflammatory SCFA production 
by microbiota that possibly metabolize pectin. To exclude this, 
we quantified the concentration of organic acids (lactic acid and 
succinic acid) and SCFAs (acetic acid, propionic acid, iso-butyric 
acid, butyric acid, iso-valeric acid, and valeric acid) in cecum 
samples from mice (Figure  6) after doxorubicin and/or pectin 
treatments. SCFAs were not enhanced and therefore cannot be 
responsible for attenuation of immune responses. Butyric and 
valeric acid were significantly reduced by doxorubicin treatment 
(p < 0.05), which was not prevented by pectin treatment (p < 0.05) 
(Figure 6). Administration of a TLR2 blocking antibody alone 
also reduced butyric and valeric acid levels (p < 0.05) (Figure 6), 
suggesting that these changes might be due to TLR2 blocking in 
the colon.
DiscUssiOn
Despite intensive research and recognition of the importance 
of dietary fibers for human health (8), little is known about the 
mechanism or the structures on fibers responsible for immu-
nomodulatory effects. Much attention has been focused on 
effects of microbial degradation products of dietary fibers such as 
immune regulatory SCFA (45, 46) but as shown here this cannot 
explain all the immune effects of widely consumed dietary fibers 
such as pectins which does not enhance SCFA but still exhibits a 
pronounced anti-inflammatory effect. Direct binding of dietary 
fibers and activation of PRRs has been suggested before as pos-
sible mechanism for immunomodulation (47), but inhibition 
of proinflammatory PRRs has to the best of our knowledge not 
been studied or suggested before.
FigUre 4 | Pectin inhibits toll-like receptor 2 (TLR2)–TLR1 activation in human dendritic cells and mouse macrophage RAW264.7 cells. (a) IL-10 and IL-6 levels in 
human dendritic cells after P3CSK4 activation with or without pectin DM7 or DM75 pretreatment (n = 5). (B) IL-6 levels in RAW264.7 cells after P3CSK4 activation 
with or without pectin DM7 or DM75 pretreatment (n = 3). Data are presented as the mean ± SD, and statistical significance was calculated using the Mann–
Whitney U-test (*p < 0.05 and **p < 0.01).
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Here, we show that the dietary fiber pectin can inhibit TLR2, 
attenuate immune responses in vitro and in vivo. This effect is 
dependent on DM of pectin. Also, we identified by applying 
targeted designed mutants of TLR2 the binding sites in TLR2 
for low-DM pectin. In addition, we demonstrate the potential 
clinical applicability of the obtained insights by testing low-DM 
pectins in a well-established TLR2-dependent ileitis model (37) 
in which it blocked ileitis as efficacious as TLR2 antibodies. 
Our work provides novel insights into mechanisms of health 
promoting effects of dietary fibers and demonstrates how 
 structure–function studies can assist in design of effective dietary 
fiber formulations.
Pectin as a dietary fiber has been demonstrated to have dif-
ferent immune effects depending on its chemical composition 
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FigUre 5 | Continued
FigUre 5 | Low-DM pectin is protective against doxorubicin-induced ileitis through toll-like receptor 2 (TLR2)–TLR1 inhibition. (a) Neutrophils (indicated by arrows) 
in peritoneal lavage stained with Giemsa. (B) Ileal apoptotic cells (indicated by arrows) determined using the TUNEL assay. Stained cells were counted in 10 
sequential crypts per mouse. (c) Cytokine and chemokine levels in peritoneal fluid (n = 6). Data are presented as the median ± range, and statistical differences 
were calculated using the Mann–Whitney U-test (*p < 0.05 and **p < 0.01).
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(18, 19, 48). One of the mechanisms for immunomodulation by 
pectin was suggested to be by inhibition of TLR4 (18, 19). 
However, the inhibition was by sequestering of LPS by pectin 
(18), and a true blocking of TLR4 receptor by pectin was not 
confirmed (18, 19). Recently, even stimulation of TLR4 by pectins 
has been reported (49). In our reporter cell line assays, we did 
not observe a substantial activation or inhibition of TLR4 which 
might be due to different size (19), composition or origin of pectin 
fibers used in our study compared with previous studies (18, 19, 
48, 49). The lemon pectins used in our study are virtually of the 
same size, same origin, and only differ in the level of methyl 
esterifications, allowing sound comparison and demonstration of 
a clear structure–function relationship for immunomodulatory 
effects of pectin.
The TLR2 inhibition was both dependent on concentration 
and DM value of pectin. The low-DM pectin showed the highest 
efficiency in TLR2 inhibition at low concentrations. Whereas at 
high concentrations, both high- and low-DM pectin could inhibit 
TLR2 with similar efficiencies. The concentration-dependent 
effect can be explained by charge densities on pectins at different 
concentrations. Low-DM pectins have higher levels of unesteri-
fied regions and are more charged compared with high-DM pec-
tins (50). At higher concentrations, high-DM pectins have more 
effective concentrations of unesterified galacturonic acid patches 
than at low concentrations. Thus, due to this higher effective 
concentration of unesterified regions on pectin, high-DM pectin 
inhibits TLR2 more efficiently at higher concentrations. Similar 
phenomena have also been observed in enhanced gel formation 
FigUre 6 | The anti-inflammatory effect of low-DM pectin is due to toll-like receptor 2 (TLR2)–TLR1 inhibition versus short-chain fatty acids (SCFAs). SCFA 
concentrations in cecum samples from mice after doxorubicin treatment with pectin (n = 6). Data are presented as the median ± range, and statistical differences 
were calculated using the Mann–Whitney U-test (*p < 0.05).
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by high-DM pectin at increased concentrations due to more 
effective concentration of free carboxyl groups of galacturonic 
acids in pectin (50, 51).
The TLR2 inhibition by pectin was specific for TLR2–TLR1 
and did not occur for TLR2–TLR6, although pectin is able to 
bind to TLR2 ectodomain. This difference may be due to the 
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FigUre 7 | Proposed mechanism of anti-inflammatory effects due to low-DM pectin. Dietary fiber low-DM pectin binds to toll-like receptor 2 (TLR2), which results in 
inhibitions of TLR2–TLR1 heterodimer activation and thus reduced NF-κB activation.
different kinetics of interaction forces between TLR2–TLR1 and 
TLR2–TLR6 interfaces. TLR2–TLR1 binding is governed both 
by ionic and hydrophobic forces (35), whereas binding at the 
TLR2–TLR6 interface is mainly through hydrophobic forces (52). 
Pectins, and especially low-DM pectins being highly charged 
molecules that are hydrophilic in nature (53), might therefore 
interfere with ionic TLR2–TLR1 interactions without hampering 
TLR2–TLR6 hydrophobic interactions. This argument is sup-
ported by our observation of DM-dependent binding of pectin 
to the TLR2 ectodomain (Figure  3C). The TLR2 ectodomain 
demonstrated a high binding of low-DM pectins but a minimal 
binding of high-DM pectins. This charge dependent binding of 
low-DM pectin with TLR2 was also observed with TLR2 mutant 
constructs. However, when comparing binding of pectin to the 
TLR2 ectodomain with that to the TLR2 mutants we observed 
a higher binding in TLR2 mutants which might be due to the 
full-length TLR2 construct used in mutants. The full-length 
TLR2 mutants contain in addition to the ectodomain also the 
intermembrane domain and the intracellular domain of TLR2 
(35, 52). Presence of these extra domains in TLR2 mutants might 
enhance the capacity to bind to pectin. While comparing TLR2 
mutants, we observed differences in mutants with different levels 
of charges. We showed that the positively charged amino acids 
surrounding the TLR2 ligand binding site are important for bind-
ing with low-DM pectin and not for high-DM pectin binding. 
This suggests that the binding between TLR2 and pectin is mainly 
due to electrostatic forces as TLR2 mutants having less positive 
charge, i.e., TLR2-QQQQ bound at lower affinity with negatively 
charged DM7 pectin while having similar binding affinity with 
DM75 pectin having lower charge densities.
The TLR2 inhibiting properties of low-DM pectin were further 
confirmed in doxorubicin-induced ileitis in mice. Doxorubicin-
induced ileitis is reported to be prevented by blocking of TLR2 
(37). Low-DM pectin administration in doxorubicin-induced 
inflammation in mice reduced the symptoms. Strikingly, the anti-
inflammatory effects of pectin were as effective as TLR2 block-
ing antibody administration. The proinflammatory cytokine 
production in peritoneal fluid was reduced after pectin  adminis- 
tration in mice treated with doxorubicin, while the regulatory 
IL-10 cytokine remained unchanged. Pectin administration did 
not enhance SCFA levels, again confirming that the effects were 
TLR2 inhibition dependent. TLR2 blocking antibody treatment 
alone showed reduction in butyric and valeric acid. The effects 
might be due to side effects of antibody treatment in cecum as this 
was not observed with pectin treatment. These observations sub-
stantiate the importance of dietary fibers like pectin as potential 
therapeutic anti-inflammatory molecules which might be useful 
in treating immunological disorders of intestinal origin. TLR2 
signaling is responsible for inflammation in doxorubicin-induced 
ileitis. However, in other contexts, TLR2 signaling may be benefi-
cial as TLR2 signaling has also been shown to induce tolerogenic 
immune responses through induction of regulatory T cells (54). 
For example TLR2 ligands, have been shown to be protective 
effects against autoimmune diseases such as multiple sclerosis 
(55). Thus, both inhibiting and activating dietary fibers may be 
instrumental in managing specific diseases and it is of utmost 
importance to determine mechanisms of anti-inflammatory 
effects of dietary fibers in specific contexts to benefit from dietary 
fibers.
In this study, we demonstrate that dietary pectins with a low 
DM can effectively bind to TLR2 at low concentrations and prevent 
proinflammatory responses, even in the presence of a TLR2–TLR1 
stimulus. As pectin is specific for inhibition of TLR2–TLR1, the 
regulatory TLR2–TLR6 (44) heterodimer signaling remained intact, 
and thus tolerogenic immune responses remained unaffected. In 
Figure  7, we propose a mechanism by which pectins suppress 
TLR2–TLR1 by direct blocking of TLR2 receptor. TLR2–TLR1 
inhibition by pectin was also effective in preventing an intestinal 
disorder in which intestinal inflammation is exacerbated by TLR2 
activation. Inflamed intestinal lesions through release of DAMPs 
such as high-mobility group box-1, leading to proinflammatory 
cytokine release (56) and intestinal damage through TLR2 (57) was 
prevented by oral pectin administration. The anti-inflammatory 
effects of pectin via TLR2–TLR1 inhibition can be an effective 
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strategy in rationally designing dietary fiber formulations to pre-
vent or cure inflammation and may even provide an explanation 
as to why increased dietary fiber intake is associated with a lower 
frequency of immunological disorders (8, 48).
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FigUre s1 | Direct ELISA to test binding of Toll-like Receptor 2 to pectin.
FigUre s2 | Pectin inhibits Heat killed Listeria monocytogenes (HKLM) 
stimulated Toll-like Receptor (TLR) 2. TLR inhibition in HEK reporter cell lines for 
TLR2 which were pretreated with pectin followed by activation by HKLM (n=5). 
Data are presented as the mean ± SD, and statistical significance was calculated 
using two-way ANOVA analysis (*p<0.001).
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